Olaplex (NASDAQ:OLPX) Given New $1.40 Price Target at Barclays

Olaplex (NASDAQ:OLPX) had its target price increased by Barclays from $1.20 to $1.40 in a research report released on Monday,Benzinga reports. The firm currently has an equal weight rating on the stock.

Separately, Telsey Advisory Group restated a “market perform” rating and set a $2.00 price objective on shares of Olaplex in a research note on Friday, May 9th.

Olaplex Price Performance

Shares of OLPX opened at $1.28 on Monday. The company has a market cap of $852.17 million, a P/E ratio of 21.34 and a beta of 2.37. The stock has a fifty day moving average price of $1.28 and a 200 day moving average price of $1.57. The company has a debt-to-equity ratio of 0.73, a current ratio of 11.84 and a quick ratio of 10.32. Olaplex has a 12 month low of $1.01 and a 12 month high of $2.77.

Olaplex (NASDAQ:OLPX) last issued its quarterly earnings data on Thursday, May 8th. The company reported $0.00 EPS for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.02). The company had revenue of $96.98 million for the quarter, compared to the consensus estimate of $93.82 million. Olaplex had a return on equity of 10.50% and a net margin of 9.78%. Olaplex’s quarterly revenue was down 1.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.03 earnings per share. On average, research analysts forecast that Olaplex will post 0.1 earnings per share for the current year.

Insiders Place Their Bets

In other Olaplex news, General Counsel John C. Duffy sold 35,013 shares of the business’s stock in a transaction on Friday, March 7th. The stock was sold at an average price of $1.44, for a total transaction of $50,418.72. Following the completion of the transaction, the general counsel now owns 348,630 shares in the company, valued at approximately $502,027.20. The trade was a 9.13% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Trisha L. Fox sold 26,526 shares of the business’s stock in a transaction on Friday, March 7th. The stock was sold at an average price of $1.44, for a total value of $38,197.44. Following the transaction, the insider now owns 461,548 shares of the company’s stock, valued at $664,629.12. This trade represents a 5.43% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 73,269 shares of company stock worth $103,161. 4.30% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the business. T. Rowe Price Investment Management Inc. lifted its holdings in shares of Olaplex by 12.5% in the first quarter. T. Rowe Price Investment Management Inc. now owns 27,567,214 shares of the company’s stock valued at $35,011,000 after buying an additional 3,066,614 shares during the period. Boston Partners lifted its holdings in shares of Olaplex by 276.0% in the fourth quarter. Boston Partners now owns 6,674,169 shares of the company’s stock valued at $11,257,000 after buying an additional 4,899,171 shares during the period. Ninety One UK Ltd lifted its holdings in shares of Olaplex by 99.3% in the fourth quarter. Ninety One UK Ltd now owns 4,239,796 shares of the company’s stock valued at $7,335,000 after buying an additional 2,112,009 shares during the period. Renaissance Technologies LLC lifted its holdings in shares of Olaplex by 9.6% in the fourth quarter. Renaissance Technologies LLC now owns 3,076,969 shares of the company’s stock valued at $5,323,000 after buying an additional 268,969 shares during the period. Finally, Dimensional Fund Advisors LP lifted its holdings in shares of Olaplex by 162.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,316,519 shares of the company’s stock valued at $4,008,000 after buying an additional 1,432,400 shares during the period. Institutional investors and hedge funds own 87.37% of the company’s stock.

Olaplex Company Profile

Olaplex Holdings, Inc develops, manufactures, and sells hair care products in the United States and internationally. The company offers hair care shampoos and conditioners for use in treatment, maintenance, and protection of hair, as well as oil, moisture mask, and nourishing hair serum. It provides hair care products to professional hair salons, retailers, and everyday consumers.